FDA Adverse Event Death Summary report: N

STIMULAN RAPID CURE

MDR report key: 7369050 · Received March 26, 2018

Report

Report Number
9617083-2018-00001
Event Type
Death
Date Received
March 26, 2018
Date of Event
February 5, 2018
Report Date
March 6, 2018
Manufacturer
BIOCOMPOSITES LTD
Product Code
MQV
UDI-DI
50601557110270
PMA / PMN Number
K141830
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AK, US
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

THE ISSUE WAS FIRST IDENTIFIED 48 HOURS POST OP, IT WASN'T ANTICIPATED BUT REPORTED THAT IN RETROSPECT AFTER REVIEWING OR NOTES AND FINDING THE AMOUNT OF TOBRAMYCIN USED, IT COULD HAVE BEEN ANTICIPATED. INITIALLY TO RESOLVE THE ISSUE A FEMORAL DIALYSIS CATHETER WAS PLACED AND THE PATIENT WAS TRANSFERRED TO A HIGHER LEVEL OF CARE (FACILITY WITH NEPHROLOGY SERVICE). SURGEON STATED THAT THE AKI COULD BE RELATED TO SURGERY OR SEPSIS. THERE IS NO SUGGESTION THAT STIMULAN RAPID CURE CAUSED OR CONTRIBUTED TO THE PATIENTS RENAL FAILURE - THE SURGEON WAS TRYING TO PROLONG LIFE. THE TREATING PHYSICIAN HAS NO CONCERNS REGARDING THE DEVICE. VANCOMYCIN AND TOBRAMYCIN ARE CLINICALLY BOTH KNOWN TO BE NEPHROTOXIC AND DUE TO THE LARGE QUANTITIES USED MAY HAVE CONTRIBUTED TO THE PATIENT'S CONDITION.

Description of Event or Problem · 1

REPORT BEING SUBMITTED TO MATCH CUSTOMERS REPORT. 20 FEB 2018 IT WAS REPORTED BY THE HOSPITAL PHARMACIST THAT A PATIENT PRESENTED WITH RENAL FAILURE 48 HOURS, POST SURGERY. SURGERY - PJI, EXPLANTATION SEPTIC LEFT KNEE. THE FOLLOWING ANTIMICROBIALS WERE GIVEN POST AND PRE SURGERY: PRE-OP: 2GM CEFAZOLIN IVPB, 1500MG VANCOMYCIN IVPB BACITRACIN IRRIGATION, 2.4GM TOBRAMYCIN & 8MG VANCOMYCIN MIXED IN 80GM PMMA 2GM VANCOMYCIN MIXED WITH 5CC, STIMULAN RAPID CURE TO MAKE BEADS; 1GM VANCOMYCIN IN WOUND BED; POST-OP: 2GM NAFCILLIN IVPB. ON 29 FEB 2018 INFORMATION RECEIVED REGARDING THE DEATH OF THE PATIENT, 15 DAYS POST EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
214464 STIMULAN RAPID CURE BONE VOID FILLER MQV BIOCOMPOSITES LTD 620-005 10/17-R354 50601557110270

Patients

Seq Age Sex Outcome Treatment
1 Death| R BACITRACIN| CEFAZOLIN| NAFCILLIN| TOBRAMYCIN| VANCOMYCIN